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Abstract
Treatment effect heterogeneity occurs when individual characteristics influence the effect of
a treatment. We propose a novel, intuitive approach that combines prognostic score matching
and conditional inference trees to characterize effect heterogeneity of a randomized treatment.
One key feature that distinguishes our method from alternative approaches is that it controls
the Type I error rate, i.e., the probability of identifying effect heterogeneity if none exists.
This feature makes our technique particularly appealing in the context of clinical trials, where
there may be significant costs associated with erroneously declaring that effects differ across
population subgroups. Treatment effect heterogeneity; causal effects; conditional inference
trees; matching.
1 Introduction
Under mild assumptions, randomized experiments estimate the average causal effect (ACE) of an
intervention. However, individuals may vary in their response to intervention so that the ACE
is a poor representation of some people’s expected benefit (or harm) from the intervention, a
phenomenon often referred to as treatment effect heterogeneity [1, 2, 3]. Characterizing treatment
effect heterogeneity can reveal both “weak responder” and “strong responder” subpopulations,
leading to greater tailoring of intervention strategies.
For a given intervention, two heterogeneity-related questions arise: 1) Is the effect of the inter-
vention heterogeneous? 2) If the intervention effect is heterogeneous, how does it vary across
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individuals? Most approaches address both questions using a single model or procedure. Tradi-
tional approaches to characterizing treatment effect heterogeneity have been primarily centered
around regression modeling with interaction terms between the treatment and covariates. In such
models, the interaction term can be used to assess whether treatment effect heterogeneity exists
and also to describe heterogeneity. Alternatively, formal nonparametric tests have been developed
to test a null hypothesis of zero average treatment effect for any subpopulation defined by covari-
ates and whether the average treatment effect is identical for all subpopulations [4]. More recently,
intense interest in personalized medicine combined with a rapidly growing toolkit of flexible ma-
chine learning techniques has produced several data-driven methods for characterizing treatment
effect heterogeneity. Athey and Imbens [5] proposed the Causal Tree approach, which modifies
the traditional CART, to determine subgroups with above-average or below-average treatment ef-
fects. The Causal Tree uses MSE-based criterion expressions to build (both splitting and cross
validation) the tree and estimate the conditional average treatment effect at each leaf node over
covariate defined subpopulations. A key feature of the Causal Tree approach is that it partitions
the data into two subsets, one of which is used for subgroup construction and the other of which is
used to estimate treatment effects within these subgroups. Wager and Athey [6] extended Causal
Trees to Causal Forests, which averages treatment effect estimates over many Causal Trees. Tran
and Zheleva [7] developed a method based on the Causal Tree framework to identify thresholds
over ordinal (or continuous) treatments that trigger an effect. [8] discussed and proposed multiple
treatment effect estimation methods that specifically handle high dimensional and observational
datasets. [9] described several meta-algorithms for the estimation of conditional average treatment
effects and introduced a new meta-algorithm in a binary treatment setting that is particularly ef-
fective when there are a greater number of units in one treatment group as opposed to another.
Within a Bayesian framework, Green and Kern [10] and Hill [11] proposed methods that apply
Bayesian Adaptive Regression Trees (BART). Anoke et al. [12] offered a review of three classes
of modeling approaches, relevant representative methods for each class (BART, propensity scores
estimated with generalized boosted models (GBM) and the facilitating score (FS)) and evaluated
these methods’ ability to detect treatment effect heterogeneity in an exploratory manner.
While many of the aforementioned techniques have shown impressive abilities to identify hetero-
geneous subgroups in situations where heterogeneity exists, they are often overly aggressive in
identifying treatment effect heterogeneity when, in truth, there is none. Put more simply, most ex-
isting procedures for detecting treatment effect heterogeneity do not control Type I error. This lack
of control of Type I error is problematic in the context of randomized trials, where false declarations
of treatment effect heterogeneity for a therapeutic agent could lead to wasteful follow-up studies
and/or inappropriate off-label use in specific subpopulations. Two recently-proposed approaches
have taken initial steps to address this issue: [13] proposed two new splitting criterions within a
CART-like framework to maintain a balance between minimizing the error in estimating the treat-
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ment effect and maximizing heterogeneity, and [14] introduced a matching plus classification and
regression tree (mCART) that reduces the potential for falsely detecting treatment effect hetero-
genity. In this paper, we build on some of these ideas to propose a novel approach to characterizing
heterogeneity of a binary treatment effect on a continuous outcome, while explicitly controlling the
Type I error rate. Our Treatment Effect Heterogeneity Tree (TEHTree) method involves building a
conditional inference tree [15] using pairs of individuals matched on the prognostic score [16]. After
describing the TEHTree method and providing theoretical motivation for matching based on prog-
nostic scores, we present the results of a substantial simulation study demonstrating TEHTree’s
power under both null and alternative hypotheses and comparing its performance to the recently-
developed Causal Tree technique [5]. We also offer a comparison of the real-world performance of
the two methods using data from a recent randomized trial.
2 Method
2.1 Setup and Notation
Let Y = {Y1, . . . , Yn} be a continuous response vector for k subjects randomized to treatment Z = 0
and n − k subjects randomized to treatment Z = 1. The treatment assignments for all subjects
are denoted by Z = {Z1, . . . , Zn}. An accompanying n× p-dimensional matrix X = {X1, . . . ,Xp}
contains the p covariates for each of the n subjects with Xi = {Xi1, . . . , Xip}.
In the counterfactual framework, each individual has a pair of counterfactual outcomes (Y0i, Y1i),
where Y1i is the outcome of subject i if assigned to treatment Z = 1 and Y0i the outcome if
assigned to Z = 0. Hence, every individual has a (counterfactual, causal) treatment effect Y1i −
Y0i, and the Average Treatment Effect (ATE) is defined as the mean of these within-individual
differences, ATE = E[Y (1)− Y (0)] (we have switched to the parenthetical counterfactual notation
Y (Z) to denote the observation YZi for arbitrary i). One of the benefits of randomization is
that, under often plausible assumptions, the difference in means of randomized groups E(Y|Z =
1) − E(Y|Z = 0) estimates the ATE. The Stable Unit Treatment Value Assumption (SUTVA)
[17, 18] bundles together two assumptions: 1) the treatment assigned to an individual affects only
the outcome for that individual, and 2) there is only one “version” of treatment. In many studies,
SUTVA is plausible; a notable exception includes studies of infectious diseases in closed populations.
The other key assumption is ignorability, i.e., that treatment assignment Z is independent of the
counterfactual pair (Y (0), Y (1)). While this “no unmeasured confounding” assumption is non-
trivial in observational studies, it is satisfied by design in a randomized trial.
The counterfactual framework allows every individual i to experience a different effect of treatment,
but because study participants are typically assigned to either Z = 1 or Z = 0, these individual-
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level effects Y1i − Y0i are unobserved. However, it is possible to estimate the Conditional Average
Treatment Effect [19],
CATE(x) = E(Y (1)− Y (0)|X = x).
Because Z is randomized, ignorability holds within any subset defined by X = x, and hence
CATE(x) can be estimated from E(Y|Z = 1,X = x) − E(Y|Z = 0,X = x) ≡ µ1(x) − µ0(x).
Therefore, the key challenge to characterizing treatment effect heterogeneity in randomized studies
is to identify distinct subgroups defined by X with different CATEs. In the absence of treatment
effect heterogeneity, the null hypothesis H0 : CATE(x) = ATE ∀x holds. Most methods that seek
to characterize how CATEs vary employ flexible semi- and non-parametric techniques in an attempt
to identify regions of heterogeneity, and do not control the Type I error probability. In contrast,
our approach embeds a classical parametric regression framework within a flexible tree model,
allowing for both explicit control of the Type I error rate and characterization of treatment effect
heterogeneity when it exists. The following two sections introduce the matching and conditional
inference tree techniques that form the basis of our method.
2.2 Matching
If we observed Y1i, Y0i, and Xi for all i then standard approaches to characterizing variability in a
continuous outcome with respect to covariates could be used to estimate CATEs; for example, we
could fit a regression tree using the differences Y1i−Y0i as outcomes and Xi as predictors. However,
in most trials an individual’s outcome is observed under only one treatment, and hence Y1i−Y0i is
unobserved. So, we propose to impute it by matching each individual i assigned to Zi = 1 with a
“similar” individual j having Zj = 0 and using (Yi−Yj) to approximate Y1i−Y0i. If j is an “exact”
match for i in the sense that Xi = Xj , then we can use E(Yi − Yj |Xi = x) to estimate CATE(x).
When the number of covariates p is even moderately large and/or elements of X are continuous,
it will typically be impossible to find exact matches for most individuals. One way of overcoming
this problem is by deriving a single measure that characterizes the “distance” between individuals.
If two individuals i and j with Zi = 1 and Zj = 0 have distance dij = d between them,
E(Yi − Yj |Xi = x,Xj = x′, dij = d, Zi = 1, Zj = 0) = E(Y1i − Y0j |Xi = x,Xj = x′, dij = d)
= E(Y1i − Y0i|Xi = x, dij = d)
+ E(Y0i − Y0j |Xi = x,Xj = x′, dij = d)
= E(Y1i − Y0i|Xi = x) + ∆0ij(x,x′, d)
= CATE(x) + ∆0ij(x,x
′, d). (1)
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Hence, pairs matched according to dij can be used to estimate CATEs provided ∆
0 is small.
Note that, in general, ∆0 may be non-zero even if d = 0; it is the price paid for reducing the
multidimensional vectors x and x′ to the scalar distance d.
A number of distance measures for matching have been proposed, some of which we review briefly
here. Broadly speaking, these measures can be broken down into three categories according to how
they define “similarity”: based on the distance between covariate vectors, based on the probability of
being treated (propensity score), and based on the predicted value of the outcome (prognostic score).
Covariate-based distances such as the Mahalanobis distance are vulnerable to the dimensionality
reduction penalty alluded to above; when the number of covariates is large, ∆0(x,x′, d = ) may
be relatively large even if the scalar distance  is small (or zero) [20]. The propensity score [21, 22],
defined as the probability of receiving the treatment given the observed covariates, is often used
for matching. However, when treatment is randomized, the propensity score is unhelpful since by
design the covariates are independent of treatment assignment and as a result propensity score
matching does not make ∆0 small.
Another way of summarizing the similarity between individuals is via the prognostic score [16].
If φ(X) is sufficient for Y0, in the sense that Y0 is independent of X given φ(X), we call φ(X) a
prognostic score. Individuals with similar prognostic scores have similar predicted values of the
outcome under treatment Z = 0 (typically a control condition). If Y|X follows a homoscedastic
linear model, then E(Y0|X) is a prognostic score, which can be estimated by fitting a regression
of Y on X among those with Z = 0, then using that model to obtain predictions of the outcome
under the control condition for all individuals [22]. Matching on prognostic scores is appealing in
our context where the goal is approximate individual causal treatment effects Y1i − Y0i. As noted
above, when Y0|X follows a homoscedastic linear model, E(Y0|X) ≡ φ(X) is a prognostic score. If
two individuals i and j with Zi = 1 and Zj = 0 have the same prognostic score φ(Xi) = φ(Xj) = φ,
E(Yi − Yj | Xi = x,Xj = x′, φ, Zi = 1, Zj = 0) = E(Y1i − Y0j |Xi = x,Xj = x′, φ)
= E(Y1i − Y0i|Xi = x, φ) + E(Y0i − Y0j |Xi = x,Xj = x′, φ)
= E(Y1i − Y0i|Xi = x) + E(Y0i − Y0j |φ)
= E(Y1i − Y0i|Xi = x) + 0
= CATE(x). (2)
This result immediately implies that if dij = |φ(Xi) − φ(Xj)| = 0, then ∆0 = 0 in (1). In other
words, matching on the prognostic score yields pairs that can be used to estimate conditional
average treatment effects. Note that this result holds if X is replaced by any measurable function
m(X), so that if m captures the way in which X modifies the effect of treatment, then pairs matched
on φ(X) retain information about effect modification.
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2.3 Conditional Inference Trees
With matched pairs in hand that can be used to estimate CATE(x), the next step is to characterize
how the CATE varies with x. Our approach uses conditional inference trees, a variant of decision
trees which we briefly introduce here.
Decision trees [23] are non-parametric models based on recursively partitioning a sample into dis-
tinct subgroups that share similar outcome values. Sample partitions (or “splits”) are defined by
thresholding covariate values. The most popular and commonly used technique for building decision
trees, the Classification and Regression Tree (CART) technique, was introduced by [24]. CART
has been applied in many areas including economics [25, 26], political science [27, 10] and public
health [28, 29]. Because of its interpretability and flexibility, CART has also been incorporated
into several methods for assessing treatment effect heterogeneity, notably CausalTree [5]. One of
CART’s drawbacks is that, because it considers many possible thresholds on all possible variables
when searching for an optimal split, it has a tendency to overfit the data on hand and produce
overly complex models. This overfitting tendency can be controlled somewhat by “pruning” trees
based on a complexity parameter. However, as we show in our simulation study, even pruned
CARTs do not control the Type I error for effect heterogeneity.
One alternative to CART is the Conditional Inference Tree (CTree), proposed by [15]. The main
difference between CTrees and CARTs is in the splitting process: in CTrees, the processes for
choosing a variable to split on or to stop splitting (the “variable selection” step) and choosing an
optimal splitting threshold for the selected variable (the “splitting” step) occur sequentially, while in
CART they happen simultaneously. In the variable selection step of CTree, the decision of whether
not to continue splitting is based on a test of the global null hypothesis H0 : E(Y|X) = E(Y), which
is tested by considering all marginal null hypotheses Hm0 : E(Y|Xm) = E(Y) for m = 1, . . . , p.
In the simplest case, each Hm0 can be assessed by calculating the p-value for the slope term from
a univariate linear regression model of Y on Xm. More generally, this step can accommodate a
wide variety of models and test statistics; even if a statistic’s sampling distribution is unknown,
permutation tests can be used to calculate p-values for each partial null hypothesis. In our method,
we calculate p-values associated with the (fixed) slope term from univariate linear mixed models.
Since H0 =
⋂p
m=1H
m
0 , the global null H0 is rejected if the minimum p-value for all of the partial null
hypotheses is less than a pre-specified level of significance. Control of Type I error can be achieved
by setting this level of significance using an appropriate multiplicity adjustment to account for the
testing of the p partial null hypotheses (see Section 2.4.3). If the minimum p-value exceeds the
threshold, the tree does not split the given subset further. Otherwise, the partial null hypothesis Hs0
that results in the smallest p-value will indicate the covariate Xs that is most strongly associated
with the outcome Y and the algorithm proceeds to the next step to determine how to optimally
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threshold Xs.
Once covariate Xs has been selected for splitting, the second step of the CTree algorithm is to find
the threshold c that maximizes the discrepancy |E(Y|Xs ≤ c) − E(Y|Xs > c)|. Typically, the
process is performed over a finite set of candidate splits c = {c1, . . . , ck} which may be restricted to
ensure properties such as a minimum number of observations in the partitions defined by (Xs ≤ c)
and (Xs > c). This two-phase splitting procedure is repeated on the resulting partitions until no
more subsets are eligible for splitting.
2.4 Treatment Effect Heterogeneity Trees (TEHTrees)
We propose a two-stage approach to assessing treatment effect heterogeneity in randomized stud-
ies. In the first stage, prognostic scores are calculated and every treated subject is matched to a
control subject (with replacement) based on the prognostic score. In the second stage, within-pair
differences in the outcome along with the covariate values of the treated member of each pair are
used as inputs to a conditional inference tree. The nodes of the fitted conditional inference tree
identify subgroups across which the causal effect of treatment varies. The full algorithm is provided
below; in the sections that follow, we provide details about its key steps.
2.4.1 Full TEHTrees algorithm
1. Separate the dataset into a training and holdout sample for the purpose of constructing a
tree and for estimating treatment effects over the determined terminal nodes.
2. Fit a model to calculate prognostic scores φ using the available training data, and obtain
estimated prognostic scores φˆ for each individual in the sample. Model details for prognostic
score estimation are provided in Section 2.4.2.
3. Form a set of matched pairs {(i1, j1), (i2, j2), . . . , (ik, jk)} from the training data by matching
each treated (Z = 1) subject with one control (Z = 0) subject, with replacement, based on
φˆ. Ties are broken randomly.
4. For each pair (il, jl), calculate the within-pair difference in the outcome, δl = Yil − Yjl . Each
pair can now be viewed as a single “pseudo-individual” represented by the scalar continuous
outcome δl and the covariate vector Xl ≡ Xi.
5. Use the pseudo-individual data (δl,Xl) created in the previous step and the desired Type I
error rate as inputs to create a Treatment Effect Heterogeneity Tree (TEHTree), as described
in Section 2.4.3.
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6. Estimate the treatment effect within each terminal node of the fitted TEHTree as described
in Section 2.4.4.
The preceding algorithm assumes that a sufficient amount of data is available to create a
holdout test set of sufficient size to accurately estimate treatment effects within subgroups
defined by each terminal node. If the sample size is limited, steps 2-6 can be carried out on
the entire dataset with an in-sample estimation approach for step 6 as described in Section
2.4.4.
2.4.2 Estimating prognostic scores
We apply the Super Learner [30] to estimate the prognostic score φ(X) ≡ E(Y0|X) = E(Y|Z =
0,X). The base learners in our application consist of the sample mean, a linear model (with and
without interaction terms), a generalized additive model, a Random Forest, stepwise regression
(with and without interaction terms), and “polymars” (multivariate adaptive polynomial spline
regression) as base learners. The Super Learner estimates the performance of these base learners
using cross-validation and develops a weighted average over a combination of these methods [30].
2.4.3 Testing partial null hypotheses
Because the outcome values δi,j are derived from pairs formed by matching with replacement, inputs
to the conditional inference tree are correlated and hence a standard univariate linear regression-
based approach to evaluating the partial null hypotheses {H0m : E(Y|Xm) = E(Y)} will produce
invalid p-values. Instead, we tested partial null hypotheses by fitting univariate linear mixed models
of the form:
E(δi,j |Xim, bj) = β0 + β1Xim + bj (3)
where bj ∼ N(0, τ2) is a random intercept corresponding to the control subject in each pair. Similar
models are used to determine the optimal splitting for selected covariate Xs, replacing Xim in (3)
by 1[Xis ≥ c].
To establish proof of concept for our method, we used the Bonferroni method to adjust the marginal
hypothesis test p-values for multiple comparisons, which sets the significance threshold at αp for
desired Type I error rate α. Other less conservative adjustment methods could also be applied.
2.4.4 Treatment effect estimation
A Treatment Effect Heterogeneity Tree assigns every observation to a terminal node in the tree; if
the tree has more than one terminal node, heterogeneity in treatment effects results because the
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estimated treatment effect differs between these terminal nodes. The algorithm in Section 2.4.1
uses an out-of-sample (test/holdout set) approach to estimating heterogeneous treatment effects
that parallels the one used to develop the CausalTree method. After having generated the TEHTree
based on the training set, we determine the TEHTree terminal node that each individual in the
holdout set belongs to. Each terminal node T consists of the union of two subsets T1 = {i :
Zi = 1, i ∈ T } and T0 = {i : Zi = 0, i ∈ T }. We compute the treatment effect estimate as
∆(T ) = 1|T1|
∑
T1 Yi − 1|T0|
∑
T0 Yi. Note that, for a 1:1 randomized treatment, large discrepancies
between |T1| and |T0| are unlikely, and hence the precision of ∆(T ) will be proportional to 1√|T | .
If limited sample size precludes carving out a holdout set from the original data, a straightforward
in-sample estimation approach can be used. Let T denote the set of matched pairs from the
data belonging to each terminal node. Then, the in-sample treatment effect estimate is simply
∆(T ) = 1|T |
∑
l∈T δl. Estimation of the precision of the in-sample estimate of ∆(T ) is complicated
(relative to the out-of-sample approach) by the need to consider the correlation between matched
pairs. Due to the limited sample, we apply this in-sample approach to the data illustration in
Section 4.
2.5 Implementation
The TEHTree method was developed using a modified conditional inference tree framework and
implemented in R [31] using relevant functions in the partykit package [32]. Continuous vari-
ables were generated using the mvtnorm package [33], matching was conducted using the Matching
package [34], and all linear mixed models were fit using the nlme package [35]. The Super
Learner was used to estimate the prognostic score; base learners were the sample mean, a lin-
ear model (with and without interaction terms), a generalized additive model, a random forest,
stepwise regression (with and without interaction terms), and “polymars” (multivariate adap-
tive polynomial spline regression). Code for implementing TEHTree can be found at https:
//github.com/AshwiniKV/TEHTree.
3 Simulation Study
We conducted simulations to evaluate the TEHTrees and compare its performance to Causal Trees
[5], implemented using the package causalTree [36] with the default settings. We evaluated the
Type I error, power and other statistical properties of estimators (e.g., bias and MSE) for TEHTrees
and Causal Trees over different data generating scenarios that are documented in the Supplemen-
tary Tables 1 and 2. Factors that were varied over the scenarios included sample size (N = 100, 200,
500, 1000 and 2000), number of covariates, type of covariates (binary and continuous), coefficients,
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and pairwise correlation among covariates. The treatment variable Z was generated such that N/2
subjects received treatment (Z = 1) and the N/2 subjects received control (Z = 0). All results de-
scribed in this simulation study are based on 1,000 simulations per scenario. Continuous covariates
were generated from multivariate normal distributions with mean zero, unit variance, and varying
pairwise correlations. Binary covariates were generated as independent Binomial(1, 0.5). Contin-
uous outcomes were generated as independent N (µ, 1) with linear predictors varying according to
the scenarios described in the Supplementary Materials.
3.1 Type I Error
For a case when there is no treatment effect heterogeneity, a Type I error occurs when a tree pro-
duces more than one terminal node. We therefore generated data under two sets of scenarios where
there was no treatment effect heterogeneity. In the first set of scenarios, outcomes were generated
from a linear model with main effects for treatment and covariates (Model (M1) in Supplementary
Table 1). In these scenarios, a simple linear model including treatment and covariates correctly
specifies the prognostic score; in other words, the SuperLearner ensemble used to estimate the
prognostic score contains the correct model. Figure 1(a) displays the Type I error (in logarithmic
scale) of TEHTrees and Causal Trees for data simulted under these scenarios. In all cases, the
Type I error of TEHTrees is less than the desired 0.05 level, while The Type I error of Causal Trees
is greater than 0.05 in every scenario, usually substantially so. As the sample size increases, the
Type I error of Causal Trees increases and is approximately 1 at N = 2000 for all three scenarios;
the Type I error of TEHTrees stays constant.
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Figure 1: Results of simulations conducted over different scenarios to evaluate the Type I Error
rate for TEHTrees and Causal Trees. The plots use data generated from Model M1 and Model M2,
as specified in the Supplementary Table 1. The different scenarios associated with each model and
their parameters are further summarised in Supplmentary Table 2. The error rates are displayed
at sample sizes N = 100, 200, 500, 1000 and 2000.
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In the second set of scenarios, outcomes were generated from a linear model with main effects
of treatment and covariates, along with additional effects for thresholded versions of continuous
covariates (Model (M2) in Supplementary Table 1). In these scenarios, the SuperLearner ensemble
does not contain the true model. Figure 1(b) displays the Type I error (in logarithmic scale) for
these scenarios. The Type I error rate of TEHTrees tends to increase with sample size and is no
longer below the desired 0.05 in every scenario. However, the Type I error rate using TEHTrees is
still much lower than the Type I error rate using Causal Trees, and when the correct prognostic score
model is used, the Type I error rate is controlled. We note that this is a particularly challenging
scenario for an approach based on prognostic score matching; even modest misspecification of the
prognostic score could markedly increase the proportion of matched pairs where one individual has
X > 0 and the other has X ≤ 0, leading to the (erroneous) conclusion that treatment effects are
heterogeneous in X.
3.2 Power
We performed additional simulations to characterize the performance of TEHTrees and Causal
Trees under a number of different data generating scenarios where treatment effect heterogeneity is
driven by binary (dichotomized) covariates only, and a mixture of binary and continuous covariates.
To avoid crediting trees with incorrect splits, we defined the power for detecting treatment effect
heterogeneity as the probability that a tree produced a split on a variable having a non-zero inter-
action with treatment (i.e., one that is responsible for producing treatment effect heterogeneity).
Note that this definition of power is somewhat generous; in cases where the treatment effect inter-
acts with several different covariates, the methods are credited with rejecting the null hypothesis
if the tree splits on any of these covariates.
Figures 2(a) through 2(c) summarize the results of scenarios for Models M3 - M7 where treatment
effect heterogeneity is determined by a single covariate (X1), and hence the power is the probability
of splitting on X1. TEHTrees and Causal Trees have similar power when heterogeneity is deter-
mined by I(X1 > 0) (Figure 2(a)) and by continuous X1 (Figure 2(b)); the power of TEHTrees
is modestly lower for small sample sizes when both the indicator and continuous value contribute
to heterogeneity (Figure 2(c)). The power of TEHTrees is substantially lower across most sample
sizes for scenarios where heterogeneity is driven by I(−0.5 < X1 < 0.5) (Figure 2(d)) and sin(X1)
(Figure 2(e)).
Figure 3 displays the power of TEHTrees and Causal Trees when heterogeneity in the treatment
effect is due to two variables, X1 and X2. For these relevant models (Models M8-M10), we consid-
ered two definitions of power: splitting on either X1 or X2, and splitting on both X1 and X2. In
general, both types of power are higher for Causal Trees than TEHTrees.
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Figure 2: Power of TEHTrees and Causal Tree when data are generated according to different
scenarios for samples with N = 100, 200, 500, 1000, and 2000. These scenarios use Model M3, M4,
M5, M6 and M7. See Supplementary Materials for complete details of simulation settings.
3.3 Tree Characteristics Under Treatment Effect Heterogeneity
Figure 4 describes characteristics of TEHTrees and Causal Trees using data generated by Model M3
and Model M7. Various results are displayed in Figure 4 including the proportion of split points that
are within the middle 5% of a standard normal distribution (i.e., proportion in I = (−0.063, 0.063)
as the true split point is zero) and the number of terminal nodes.
Figure 4(a) shows the average number of terminal nodes per tree, where the average is around three
terminal nodes for TEHTrees and is much greater for Causal Trees. In Figure 4(b), the proportion
of split points in (−0.063, 0.063) for TEHTrees is greater than Causal Trees over smaller sample
sizes, but lower than Causal Trees for larger sample sizes. In Figure 4(c), the number of terminal
nodes is higher for Causal Trees over all scenarios as compared to TEHTrees. Figure 4(d) displays
the percentage of splits at variables besides X1. This percentage is higher for Causal Trees over all
scenarios and regardless of sample size.
3.4 Treatment Effect Estimation
Figure 5 describes the mean squared error (MSE) of the treatment effect estimates across data
generating scenarios and for different sample sizes. The scenarios are defined using Models M5-
M8 and M10 and are fully described in Supplementary Tables 1 and 2. Across most scenarios,
TEHTrees and CausalTrees show similar MSE, with a notable exception being the scenario for
12
(a) (b) (c)
Figure 3: Power of TEHTrees and Causal Tree when data are generated according to scenarios for
Model M8, Model M9 and Model M10. Full descriptions of individual scenarios can be found in
Supplementary Table 1 and Table 2. Power is defined to be the probability of the tree making a
split on any variable with treatment effect heterogeneity (“Power Any”) or on all variables with
treatment effect heterogeneity (“Power All”).
Model M6 in Figure 5(b) where heterogeneity is due to I(−0.5 < X1 < 0.5); this is the same
scenario displayed in Figure 2(d) where TEHTrees lacked power.
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Figure 4: Characteristics of the trees built by TEHTrees (TT) and Causal Tree (CT) when het-
erogeneity is due to I(X1 > 0) (as described in Model M3) and the sin(ηX1) term (as described in
Model M7). Figure 4(a) and Figure 4(b) correspond to data generated using Model M3 and Figure
4(c) and Figure 4(d) correspond to data generated using Model M7. The described characteristics
include the proportion of those split points that are within the middle 5% of a standard normal
distribution (i.e., proportion in I = (−0.063, 0.063) since the true split point is zero), the average
number of terminal nodes (presented in logarithmic scale) when a split is made and proportion of
splits at variables besides X1 (presented as a percentage).
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(a) (b) (c)
(d) (e)
Figure 5: Mean-squared error (MSE) of the estimated average treatment effect for subjects in the
estimation sample. Data are generated using Model M5, M6, M7, M8 and M10 and these models
are fully described in the Supplementary Materials.
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4 Illustration
In this section, we evaluate the proposed TEHTree’s ability to detect treatment effect heterogenity
against the Causal Tree approach. Both these methods are illustrated by an application to a real
world dataset from the Box Lunch Study (BLS). The Box Lunch Study [37, 38] was designed as a
randomized controlled trial to evaluate the effect of differences in lunchtime portion sizes (400 kcal,
800 kcal, 1600 kcal and no intervention) on caloric energy intake through the day and body weight
of working adults. The BLS data are composed of numerous covariates measured at six months
and includes a response to the Three Factor Eating Questionnaire (TFEQ) that quantifies hunger
and a novel laboratory-based psycho-social measure construct (wanting). The utilised BLS data
are composed of 213 subjects, where 160 subjects were allocated an intervention in the form of a
lunch box. Because of the size of the dataset, the TEHTree algorithm implemented in this section
uses the modifications specified in Section 2.4.4. In general, TEHTree’s reliance on a statistical
inference-based framework (as opposed to CART’s greedy search approach) for growing a tree
structure leads to a reduced risk of overfitting.
Both Causal Trees and TEHTrees are data-driven approaches that seek to identify subgroups that
represent above-average or below-average benefit from treatment. In other words, these approaches
determine estimates of the conditional average treatment effect (CATE). The trees are utilized to
identify groups of study subjects that exhibit significant differences in the caloric intake due to a
portion size intervention as opposed to no intervention. Relevant to this analysis, the caloric intake
through the day is utilised as an outcome of interest and covariates include hunger and wanting.
Figure 6 displays Causal Trees and TEHTrees as applied to different formulated scenarios. An ‘hon-
est’ Causal Tree (i.e., uses separate samples for building a tree structure and computing estimated
effects) is implemented using a majority of the default settings in the R package causalTree In
Figure 6(a), the Causal Tree with three terminal nodes initially splits at hunger1. For subjects with
a hunger1 value less than a value of 6, the tree splits further at wanting1. A split at hunger for
values above and equal to 6 leads to a negative effect of a change in portion size on the daily caloric
intake and the CATE for this subgroup is -370. In other words, subjects with greater measured
hunger (as specified by a quantified construct for levels above 6) may present a reduction in their
daily caloric intake if they are assigned to a portion size intervention. A split at hunger1 for values
below 6 and wanting1 greater than or equal to -27 results in a subgroup with positive treatment
effect and the CATE for this subgroup is 222. In Figure (b), the TEHTree (applied to this same
dataset) splits at wanting1 and hunger1. More specifically, a split at wanting1 for values above
6.44 shows that there is a negative treatment effect. A split at wanting1 for values less than or
equal to 6.44 and at hunger1 ≤ 6 leads to a positive effect of treatment effect. In Scenario I, a
subgroup associated with hunger below a value of 6 and wanting greater than -27 (for a Causal
Tree) or less than 6.44 (for a TEHTree) leads to subgroups with a positive treatment effect. Within
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scenario I, the covariate determined subgroups and estimated CATEs differ in magnitude but are
not necessarily contradictory.
In a different scenario, the association between caloric intake and the covariates hunger1 and
wanting1 is removed by permuting along caloric intake while maintaining the correlation between
hunger1 and wanting1. In this modified dataset, to distinguish Scenario II from Scenario I, the
covariates are labeled as hunger2 and wanting2. In Figure 6(c) and Figure 6(d), the tree frame-
works are applied to the modified dataset. Using the same settings (as for Figure 6(a)), Causal Tree
continues to find splits at wanting2 even with the removal of any association between the caloric
intake and the covariates. A split at wanting ≥ 6 results in a subgroup with a positive treatment
effect. However, at the same settings of the TEHTree (as for the TEHTree displayed in Figure
6(b)), there are no splits and a single root node with the corresponding average treatment effect is
displayed in Figure 6(d). This difference in results suggests the ability of TEHTree to control for
the false discovery of subgroups.
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(a) Causal Tree framework (b) TEHTree framework
Scenario I: No knowledge about the presence of covariates’ correlations with the outcome.
(c) Causal Tree framework (d) TEHTree framework
Scenario II: Covariates are permuted together to remove correlations with the outcome.
Figure 6: Two scenarios are formulated to demonstrate differences in estimated treatment effects
and ability to detect treatment effect heterogeneity. These tree frameworks (Causal Trees and
TEHTrees) in Scenarios (I and II) are illustrated by an application to the Box Lunch Study (BLS)
dataset. In both scenarios, the outcome of interest is energy intake through the day. Scenario I uses
covariates hunger1 and wanting1, where there is no prior knowledge about correlation between
the covariates and the outcome of interest. In Scenario II, the covariates hunger2 and wanting2
are permuted together to maintain their correlation but to remove existing correlations with the
outcome.
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5 Discussion
Characterizing treatment effect heterogeneity is becoming a common target of secondary analyses
of data from randomized controlled trials. As an alternative to methods that require that the
nature of potential subgroups be pre-specified (e.g., via covariate interactions with treatment),
several methods have been recently proposed to detect treatment effect heterogeneity in a more
data-driven manner [5, 6, 8, 9]. However, while most of these methods incorporate procedures for
preventing overfitting, they do not offer any guarantees about Type I error, i.e., the probability of
identifying heterogeneous subgroups in the absence of treatment effect heterogeneity. Particularly
in the context of randomized trials, explicit control of Type I error may increase the willingness of
researchers to apply treatment effect heterogeneity techniques. In this paper, we propose TEHTrees,
a novel method that uses a conditional inference tree framework to characterize effect heterogeneity
of a binary treatment while controlling the Type I error rate.
The ability to tailor intervention strategies to particular population subgroups is aided by the
detection of treatment effect heterogeneity. More specifically, differences from the average treatment
effect indicate patient subpopulations that receive benefit/harm from a given treatment allocation.
However, traditional approaches to treatment effect heterogeneity that identify such subgroups do
not address the issue of preserving or explicitly controlling Type I error rate. Our approach offers
the ability to explicitly control the Type I error rate and is able to preserve balance (i.e., between
the treatment and control groups) in patient characteristics by matching patients over computed
prognostic scores.
As shown in our simulation study, popular existing methods (e.g., CausalTree) yield much higher
than nominal Type I error rates, with this error rate generally increasing with sample size. In
contrast, TEHTree maintains the specified Type I error rate across a majority of scenarios; however,
for prognostic score models that are misspecified, the error rate increases with sample size (as
displayed in Figure 1(b)). In some scenarios, the power of TEHTrees to detect true heterogeneity is
competitive with CausalTree; in other scenarios, TEHTrees has lower power, but these discrepancies
arise in scenarios where CausalTree has very high Type I error rates, i.e., its power curve lies above
that of TEHTrees for both null and alternative hypotheses.
In simulation experiments, the Type I error rate using TEHTrees was below 0.05 (the pre-specified
significance level) in all the considered scenarios, while the Type I error using Causal Trees was at
least 0.15 in every scenario and even greater than 0.9 in many cases. Though Causal Trees have
slightly greater power when there are continuous covariates, compared to TEHTrees, the power
when using TEHTrees is actually greater than the power when using Causal Trees with binary
covariates. When there is ‘known’ treatment effect heterogeneity, Causal Trees also tend to grow
larger trees with more terminal nodes, particularly with larger sample sizes. This makes it more
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difficult to infer the characteristics of groups that truly respond more (or less) to treatment when
using Causal Tree compared to TEHTrees. Causal Trees displayed lower MSE than TEHTrees
in multiple scenarios, which was most likely due to greater variability in split points for TEHTree
structures. We conjecture that the variability in split points is larger for TEHTrees than with Causal
Tree and this can be attributed to the bias inroduced by the matching estimator. Decreasing bias
in the matching estimator, or using an alternative approach to estimating the outcomes that are
used as inputs in the conditional inference tree of TEHTrees, may therefore improve estimation of
treatment effects with TEHTrees when there are continuous covariates.
TEHTrees offer a flexible approach to detecting effect heterogeneity and allows for numerous mod-
ifications. However, further modifications to this method can include the choice of a different
matching algorithm, an alternative prognostic score model, the utilisation of other criterion to se-
lect the splitting variable or its split point or the implementation of a different estimation technique.
In addition, the Bonferroni correction method used to find the splitting variable in TEHTrees is
likely too conservative to detect small treatment effects when there are a large number of covariates
in the study. Alternative multiple comparison adjustment methods should be explored in the case
when there are many covariates. TEHTrees also do not account for the variability introduced by
the matching estimator, so an extra step may be required to control for the inflation of Type I error
that might occur in situations when good matches are difficult to obtain. A larger variety of scenar-
ios may also need to be considered; this can include an increase in the complexity of the prognostic
score model or to explore alternative effect sizes and treatment effect patterns (such as continuous
interactions with treatment). Additionally, though we assume treatment is randomized (as in a
clinical trial) throughout this paper, TEHTrees could be extended for use with observational data;
however, additional assumptions and steps in the algorithm would be required to achieve balance in
the covariates. Other modifications can also include extensions to account for multiple treatment
allocations as opposed to a binary treatment assignment.
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Supplementary Material
Simulation Scenarios
Continuous covariates were generated from multivariate normal distributions with mean zero, unit
variance, and varying pairwise correlations. Binary covariates were generated as independent
Binomial(1, 0.5). Continuous outcomes were generated as independentN (µ, 1) with linear predictor
µ as defined below in Suppmentary Table 1. We set α to 0.8, θ to 0.8 and β to (1.0, 0.8, 0.6, 0.4, 0.2)T
for the first five covariates (0 otherwise). The following models (M1 - M10) and their relevant pa-
rameters are used over multiple data scenarios, where data are simulated over N different sample
sizes (i.e., N = 100, 200, 500, 1000 and 2000).
Models (M1) µ = 0.8 + 0.8Z + βX
(M2) µ = 0.8 + 0.8Z + βX + φI(X > 0)
(M3) µ = 0.8 + 0.8Z + βX + γZ · I(X1 > 0)
(M4) µ = 0.8 + 0.8Z + βX + γZ ·X1
(M5) µ = 0.8 + 0.8Z + βX + γ1Z ·X1 + γ2Z · I(X1 > 0)
(M6) µ = 0.8 + 0.8Z + βX + γZ · I(−0.5 < X1 < 0.5)
(M7) µ = 0.8 + 0.8Z + βX + γZ · sin(ηX1)
(M8) µ = 0.8 + 0.8Z + βX + γ1Z · I(X1 > 0) + γ2Z · I(X2 > 0))
(M9) µ = 0.8 + 0.8Z + βX + γ1Z ·X1 + γ2Z · I(X2 > 0)
(M10) µ = 0.8 + 0.8Z + βX + γZ ·X
β = (1.0, 0.8, 0.6, 0.4, 0.2, 0, . . . , 0)T
Covariates (C1) X = 5 independent binary covariates
(C2) X = 5 independent continuous covariates
(C3) X = 10 independent continuous covariates
Coefficients (P1) φ1 = 3, φ2 = φ3 = φ4 = φ5 = 0
(P2) φ1 = 1, φ2 = φ3 = φ4 = φ5 = 0
(P3) φ1 = φ2 = 1, φ3 = φ4 = φ5 = 0
(P4) γ = 1
(P5) (i) γ = 2, (ii) γ = 1
(P6) (i) γ1 = γ2 = 1, (ii) γ1 = 1, γ2 = −1, (iii) γ1 = −1, γ2 = 1, (iv) γ1 = γ2 = −1
(P7) (i) γ = 3, (ii) γ = 2, (iii) γ = 1
(P8) (i) γ = 2, η = 2, (ii) γ = 1, η = 2, (iii) γ = 2, η = 1.5, (iv) γ = 1, η = 1.5
(P9) (i) γ1 = 3, γ2 = 3, (ii) γ1 = 1, γ2 = 1, (iii) γ1 = 3, γ2 = −3, (iv) γ1 = 1, γ2 − 3
(P10) (i) γ1 = γ2 = 1, (ii) γ1 = 1, γ2 = −1, (iii) γ1 = −1, γ2 = 1, (iv) γ1 = γ2 = −1
(P11) (i) γ = 1, (ii) γ = 2, (iii) γ = 6
Table 1: Simulation parameters
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Evaluating Type I Error
Figure 1(a)
(M1) (C1)-(C3) Correctly specified prognostic score
Figure 1(b)
(M2) (C1) (P1)-(P3) Incorrectly specified prognostic score
Evaluating Power
Figures 2(a) & 4(a)
(M3) (C1)-(C3) (P4) Heterogeneity according to I(X1 > 0)
Figure 4(b) [(i)-(iii) refers to settings (C1)-(C3)]
(M3) (C2)-(C3) (P4) [(ii)-(iii) refers to settings (C2)-(C3)]
Figure 2(b)
(M4) (C3) (P5) (i)-(ii) Heterogeneity according to X1
Figures 2(c) & 5(a)
(M5) (C3) (P6) (i)-(iv) Heterogeneity according to I(X1 > 0) and X1
Figures 2(d) & 5(b)
(M6) (C3) (P7) (i)-(iii) Heterogeneity according to I(−0.5 < X1 < 0.5)
Figures 2(e) & 5(c)
Figures 4(c) & 4(d) Heterogeneity according to sin(X1)
(M7) (C3) (P8) (i)-(iv)
Figures 3(a) & 5(d)
(M8) (C3) (P9) (i)-(iv) Heterogeneity according to I(X1 > 0) and I(X2 > 0)
Figure 3(b)
(M9) (C3) (P10) (i)-(iv) Heterogeneity according to X1 and I(X2 > 0)
Figures 3(c) & 5(e)
(M10) (C3) (P11) (i)-(iii) Heterogeneity according to X1, . . . , X10
Table 2: Simulation scenarios corresponding to main figures. Scenario codes are full described in
Table 1.
Additional scenarios for Models M1 - M10
The results evaluated using Model M1 and Model M2 were displayed in Figures 1(a) and 1(b) using
data generated over N = 100, 200, 500, 1000 and 2000. However, the results displayed in Figures
1(a) assume the absence of pairwise correlation (ρ = 0) among the five covariates. Supplementary
Table 3 present results for non-zero values of pairwise correlation (ρ = 0.2, ρ = 0.4, ρ = 0.6, ρ = 0.8)
over continuous covariates (m = 5) at N = 200 and N = 500. Similarly, Model M2 was varied using
different vectors of coefficients for five continous covariates and Supplementary Table 4 presents
results for two additional vectors of coefficients.
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Table 3: Type I Error rate when there is no treatment effect heterogeneity (i.e., when γ = 0) and
the data are generated according to Model M1.
Covariate Type N m ρ Type I Error Rate
TT CT
Continuous 200 5 0.2 0.030 0.687
Continuous 200 5 0.4 0.026 0.767
Continuous 200 5 0.6 0.026 0.825
Continuous 200 5 0.8 0.050 0.851
Continuous 500 5 0.2 0.023 0.970
Continuous 500 5 0.4 0.026 0.991
Continuous 500 5 0.6 0.030 0.994
Continuous 500 5 0.8 0.045 0.998
Table 4: Type I Error rate of TEHTrees and Causal Tree when there is no treatment effect het-
erogeneity and the data are generated according to Model M2. The last column shows the Type I
Error of TEHTrees when the true prognostic scores are used in matching.
N m φ1 φ2 φ3 φ4 φ5 Type I Error Rate
TT CT TT (true PS)
100 5 0.5 1 0 0 0 0.024 0.429 0.053
200 5 0.5 1 0 0 0 0.021 0.627 0.052
500 5 0.5 1 0 0 0 0.031 0.904 0.062
1000 5 0.5 1 0 0 0 0.056 0.986 0.048
2000 5 0.5 1 0 0 0 0.155 0.995 0.060
100 5 1 1 1 1 1 0.026 0.433 0.053
200 5 1 1 1 1 1 0.019 0.677 0.046
500 5 1 1 1 1 1 0.032 0.956 0.044
1000 5 1 1 1 1 1 0.092 0.997 0.046
2000 5 1 1 1 1 1 0.144 0.998 0.054
Table 5: Power of TEHTrees and Causal Trees when data are generated according to Model M3
and there is treatment effect heterogeneity.
Covariate Type N m ρ Power
TT CT
Continuous 200 5 0.2 0.68 0.93
Continuous 200 5 0.4 0.72 0.89
Continuous 200 5 0.6 0.73 0.88
Continuous 200 5 0.8 0.66 0.83
Continuous 500 5 0.2 0.97 0.98
Continuous 500 5 0.4 0.98 0.98
Continuous 500 5 0.6 0.98 0.95
Continuous 500 5 0.8 0.95 0.94
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Table 6: Characteristics of the trees including the median and mean of the first split point on X1
(the variable with heterogeneous treatment effects). Data are generated using Model M3.
Covariate N m ρ Median Mean
type split point split point
TT CT TT CT
Continuous 100 5 0.0 -0.01 -0.01 -0.01 -0.01
Continuous 200 5 0.0 0.00 0.00 0.00 0.00
Continuous 500 5 0.0 0.00 0.00 0.00 0.00
Continuous 1000 5 0.0 0.00 -0.00 0.00 -0.00
Continuous 2000 5 0.0 0.00 -0.00 0.00 -0.00
Continuous 100 10 0.0 -0.01 -0.03 -0.03 -0.02
Continuous 200 10 0.0 0.00 0.01 0.02 0.01
Continuous 500 10 0.0 0.00 0.00 0.00 0.00
Continuous 1000 10 0.0 0.00 0.00 0.00 0.00
Continuous 2000 10 0.0 0.00 0.00 0.00 -0.00
Continuous 200 5 0.2 0.00 0.00 0.00 0.00
Continuous 200 5 0.4 0.00 -0.00 0.00 -0.00
Continuous 200 5 0.6 0.00 0.00 -0.01 -0.00
Continuous 200 5 0.8 0.00 0.00 0.01 -0.01
Continuous 500 5 0.2 0.00 -0.00 0.00 -0.00
Continuous 500 5 0.4 0.00 -0.00 -0.01 -0.00
Continuous 500 5 0.6 -0.01 -0.00 0.00 -0.00
Continuous 500 5 0.8 -0.01 -0.00 -0.01 -0.01
Table 7: Power and MSE of the estimated average treatment effect for TEHTrees and Causal Tree
when data are generated according to Model M4. Power is defined to be the probability of the tree
making a split on X1.
γ N ρ Power # nodes % non-X1 split MSE
TT CT TT CT TT CT TT CT
1 200 0.2 0.70 0.83 2.15 5.09 0.05 0.87 0.89 1.22
1 500 0.2 0.99 0.99 2.90 11.53 0.09 0.99 0.50 0.80
1 200 0.4 0.76 0.80 2.20 5.18 0.09 0.90 0.93 1.28
1 500 0.4 1.00 0.98 2.99 11.60 0.13 0.99 0.52 0.85
1 200 0.6 0.74 0.76 2.25 5.22 0.17 0.91 0.97 1.26
1 500 0.6 0.99 0.96 3.10 11.11 0.19 0.97 0.51 0.82
1 200 0.8 0.64 0.71 2.24 5.21 0.29 0.89 1.01 1.09
1 500 0.8 0.96 0.93 3.20 10.88 0.33 0.96 0.52 0.70
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Table 8: Power and MSE of the estimated average treatment effect for TEHTrees (TT) and Causal
Tree (CT) when data are generated according to Model M5. Power is defined to be the probability
of the tree making a split on X1.
γ1 γ2 N ρ Power # nodes % non-X1 split MSE
TT CT TT CT TT CT TT CT
-1 -1 200 0.2 0.82 0.95 2.14 4.42 0.06 0.68 1.14 1.04
-1 -1 500 0.2 1.00 1.00 2.71 10.46 0.15 0.92 0.59 0.69
-1 -1 200 0.4 0.81 0.98 2.19 4.95 0.13 0.82 1.16 1.06
-1 -1 500 0.4 1.00 1.00 2.88 11.36 0.29 0.99 0.59 0.70
-1 -1 200 0.6 0.81 0.96 2.26 5.03 0.23 0.86 1.14 1.04
-1 -1 500 0.6 1.00 1.00 3.16 11.32 0.44 0.98 0.58 0.66
-1 -1 200 0.8 0.68 0.93 2.37 5.03 0.42 0.91 1.09 0.92
-1 -1 500 0.8 0.96 1.00 3.44 11.01 0.60 0.98 0.57 0.59
Table 9: Power and MSE of the estimated average treatment effect for TEHTrees and Causal Tree
when data are generated according to Model M6. Power is defined to be the probability of the tree
making a split on X1.
γ N ρ Power # nodes % non-X1 split N MSE
TT CT TT CT TT CT TT CT
3 200 0.2 0.13 1.00 2.88 19.59 0.17 0.99 1000 1.97 0.57
3 500 0.2 0.31 1.00 3.48 38.13 0.40 1.00 2000 1.64 0.43
3 200 0.4 0.13 1.00 2.83 21.14 0.21 1.00 1000 1.98 0.60
3 500 0.4 0.35 1.00 3.60 38.00 0.47 1.00 2000 1.66 0.42
3 200 0.6 0.15 0.99 2.85 20.30 0.28 0.99 1000 1.97 0.58
3 500 0.6 0.36 1.00 3.63 36.76 0.53 1.00 2000 1.70 0.39
3 200 0.8 0.17 0.98 2.97 19.36 0.32 0.98 1000 1.97 0.54
3 500 0.8 0.32 1.00 3.42 33.33 0.59 1.00 2000 1.75 0.33
Table 10: Power and MSE of the estimated average treatment effect for TEHTrees (TT) and Causal
Tree (CT) when data are generated according to Model M7. Power is defined to be the probability
of the tree making a split on X1.
γ N η ρ Power # nodes % non-X1 split MSE
TT CT TT CT TT CT TT CT
2 200 1.5 0.2 0.40 0.96 2.10 4.90 0.04 1.62 1.95 1.82
2 500 1.5 0.2 0.77 1.00 2.23 11.20 0.06 0.97 1.42 1.37
2 200 1.5 0.4 0.48 0.94 2.10 5.14 0.04 0.87 1.94 1.87
2 500 1.5 0.4 0.86 0.99 2.24 11.52 0.08 0.98 1.38 1.40
2 200 1.5 0.6 0.49 0.92 2.11 5.20 0.09 0.88 1.98 1.86
2 500 1.5 0.6 0.87 0.99 2.26 11.24 0.10 0.98 1.38 1.35
2 200 1.5 0.8 0.47 0.86 2.15 5.13 0.16 0.88 2.05 1.80
2 500 1.5 0.8 0.83 0.98 2.30 10.82 0.17 0.97 1.43 1.26
25
Table 11: Power and MSE of the estimated average treatment effect using TEHTrees (TT) and
Causal Trees (CT) when data are generated according to Model M8. Power is defined to be the
probability of making a split on X1 or X1 (“Power Any”) or on X1 and X2 (“Power All”)
γ1 γ2 N ρ Power Any Power All # nodes N MSE
TT CT TT CT TT CT TT CT
3 3 200 0.2 0.75 0.94 0.28 0.78 2.49 5.01 1000 4.83 5.23
3 3 500 0.2 0.96 0.99 0.92 0.97 3.91 9.87 2000 4.59 4.93
3 3 200 0.4 0.88 0.92 0.31 0.71 2.56 4.99 1000 4.89 5.32
3 3 500 0.4 1.00 0.98 0.95 0.97 3.92 10.21 2000 4.56 4.92
3 3 200 0.6 0.94 0.91 0.28 0.64 2.57 4.92 1000 4.99 5.27
3 3 500 0.6 1.00 0.97 0.91 0.96 3.83 10.11 2000 4.52 4.86
3 3 200 0.8 0.92 0.91 0.21 0.58 2.58 4.97 1000 5.02 5.18
3 3 500 0.8 1.00 0.98 0.71 0.95 3.52 9.87 2000 4.58 4.82
Table 12: Power and MSE of the estimated average treatment effect for TEHTrees (TT) and Causal
Tree (CT) when data are generated according to Model M9. Power is defined to be the probability
of making a split on X1 or X1 (“Power Any”) or on X1 and X2 (“Power All”).
γ1 γ2 N ρ Power Any Power All # nodes MSE
TT CT TT CT TT CT TT CT
-1 -1 200 0.2 0.60 0.93 0.04 0.48 2.17 4.69 1.19 1.11
-1 -1 500 0.2 0.99 1.00 0.40 0.90 3.17 10.69 0.77 0.76
-1 -1 200 0.4 0.75 0.97 0.05 0.55 2.22 5.04 1.21 1.15
-1 -1 500 0.4 1.00 1.00 0.49 0.94 3.51 11.64 0.77 0.79
-1 -1 200 0.6 0.79 0.96 0.07 0.50 2.29 5.07 1.21 1.10
-1 -1 500 0.6 0.99 1.00 0.52 0.93 3.75 11.77 0.74 0.76
-1 -1 200 0.8 0.74 0.93 0.08 0.46 2.39 5.02 1.11 0.98
-1 -1 500 0.8 0.97 1.00 0.42 0.88 3.83 10.95 0.66 0.64
Table 13: Power and MSE of the estimated average treatment effect for TEHTrees (TT) and Causal
Tree (CT) when data are generated according to Model M10. Power is defined to be the probability
of the tree making a split on any variables (“Power Any”) or on all variables with treatment effect
heterogeneity (“Power All”). γ is the coefficient of the interaction term.
γ Vars N ρ Power Any Power All # nodes MSE
int. TT CT TT CT TT CT TT CT
6 12 200 0.2 0.15 0.47 0.04 0.37 2.32 5.87 37.45 34.62
6 12 500 0.2 0.39 0.88 0.12 0.86 2.84 14.01 36.23 24.69
6 12 200 0.4 0.16 0.67 0.04 0.50 2.39 5.62 41.59 36.66
6 12 500 0.4 0.42 0.98 0.12 0.97 2.83 14.77 39.48 23.26
6 12 200 0.6 0.20 0.89 0.05 0.70 2.53 6.17 47.96 35.62
6 12 500 0.6 0.43 1.00 0.12 1.00 2.90 15.35 43.91 22.28
6 12 200 0.8 0.23 0.98 0.06 0.78 2.75 6.47 55.66 32.80
6 12 500 0.8 0.43 1.00 0.14 1.00 3.16 14.93 47.57 20.80
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